The physiological mechanisms associated with Aβ and tau production/secretion/clearance in the brain indicate a potential impact of neuronal activity on the changes in CSF biomarkers in PSP, providing insights into the pathological mechanisms of this disease. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.